DA Davidson Maintains Underperform on Medifast, Maintains $17.5 Price Target
Benzinga Newsdesk 2 years ago
NewsPrice TargetAnalyst Ratings
DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Underperform and maintains $17.5 price target.
DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Underperform and maintains $17.5 price target.